Ainos, Inc. is projected to decline to $1.41 by 2027, a -3% move from its current price of $1.45. AIMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.39 | $1.45 | $1.51 | 0.00% |
| Aug 6 | $1.37 | $1.45 | $1.54 | -0.01% |
| Aug 7 | $1.35 | $1.45 | $1.56 | -0.01% |
| Aug 8 | $1.34 | $1.45 | $1.57 | -0.02% |
| Aug 9 | $1.32 | $1.45 | $1.59 | -0.02% |
| Aug 10 | $1.31 | $1.45 | $1.60 | -0.03% |
| Aug 11 | $1.30 | $1.45 | $1.62 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.30 | $1.45 | $1.62 | -0.03% |
| Week 2 | $1.24 | $1.45 | $1.69 | -0.07% |
| Week 3 | $1.20 | $1.45 | $1.75 | -0.10% |
| Week 4 | $1.16 | $1.45 | $1.80 | -0.13% |
| Week 5 | $1.13 | $1.45 | $1.85 | -0.17% |
| Week 6 | $1.11 | $1.45 | $1.89 | -0.20% |
| Week 7 | $1.08 | $1.45 | $1.93 | -0.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ainos, Inc. is a dual-platform technology company focusing artificial intelligence-based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data.
Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. It is a subsidiary of Taiwan Carbon Nano Technology Corporation. The company was formerly known as Amarillo Biosciences, Inc.
and changed its name to Ainos, Inc. in May 2021. It provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors.
Ainos, Inc. (AIMD) is a listed technology company with current price $1.40 and a market cap of $10.31M. It ranks 4860 by market capitalization. The price outlook is drawn from the latest forecast, which shows mixed near-term momentum and a longer-run bullish trajectory; the forecast highlights volatility and a path from near-term weakness to meaningful upside later in the decade.
A major floor 42.8% below — a decisive break under it would weaken the trend.
The nearest floor, 9.7% below — buyers have tended to step in here.
The nearest ceiling, 40.7% above — a clean break opens room to run.
A major ceiling 117.9% above — clearing it would confirm fresh momentum.
Key AIMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AIMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.33 | Buy | $1.36 | Buy |
| MA 10 | $1.43 | Buy | $1.44 | Buy |
| MA 20 | $1.64 | Sell | $1.57 | Sell |
| MA 50 | $1.87 | Sell | $1.72 | Sell |
| MA 100 | $1.74 | Sell | $1.81 | Sell |
| MA 200 | $2.00 | Sell | $2.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.98 | Neutral |
| Stoch RSI (14) | 12.71 | Buy |
| CCI (20) | -95.72 | Neutral |
| Williams %R (14) | -96.67 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -30.37 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 3.33 | Buy |
| TRIX (15) | -0.96 | Sell |
| Awesome (5,34) | -0.41 | Sell |
| Ultimate (7,14,28) | 16.73 | Buy |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.29 | Buy |
| ADX (14) | 21.45 | Sell |
| ATR (14) | 0.06 | Info |
The sentiment is BEARISH with an RSI14 of 40. The price is trading below the SMA50 of $1.91 and the SMA200 of $2.07, aligning with a cautious near-term bias. The 30-day range spans from $1.04 to $1.88, with support at $1.51 and resistance at $2.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.29 | $1.45 | $1.88 | 0% | Neutral | |
| $1.07 | $1.41 | $1.99 | -3% | Neutral | |
| $1.07 | $1.47 | $2.18 | +1% | Neutral | |
| $0.9152 | $1.31 | $2.02 | -10% | Neutral | |
| $0.7776 | $1.15 | $1.84 | -21% | Bearish | |
| $0.9322 | $1.42 | $2.34 | -2% | Neutral | |
| $1.01 | $1.58 | $2.67 | +9% | Neutral | |
| $1.07 | $1.72 | $2.98 | +19% | Neutral | |
| $1.15 | $1.90 | $3.36 | +31% | Bullish | |
| $1.01 | $1.71 | $3.09 | +18% | Neutral | |
| $1.35 | $2.58 | $5.05 | +78% | Bullish | |
| $1.53 | $3.40 | $7.47 | +134% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.29 | $1.45 | $1.75 | +0.00% |
| September 2026 | $1.16 | $1.40 | $1.74 | -3.64% |
| October 2026 | $1.19 | $1.44 | $1.82 | +3.32% |
| November 2026 | $1.22 | $1.49 | $1.90 | +2.94% |
| December 2026 | $1.18 | $1.45 | $1.88 | -2.33% |
Click any year to see its month-by-month AIMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AIMD to range from $1.29 to $1.88 through 2026. The $1.45 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AIMD price prediction for 2027 points to an average of $1.41 (low $1.07, high $1.99) — a potential decline of -3% on today's $1.45. A consolidation phase looks the most probable path here.
In 2028, AIMD is projected to trade between $1.07 and $2.18, averaging $1.47 — a potential gain of +1% from today's $1.45. That is up +4% on the projected 2027 average. Price action looks broadly range-bound.
Ainos, Inc.'s 2029 outlook centres on $1.31, within a $0.9152 to $2.02 range. That is -11% versus the projected 2028 average. That marks a -10% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, AIMD could reach as high as $1.84, with a base case around $1.15 and support toward $0.7776 — roughly -21% from $1.45. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect AIMD to range from $0.9322 to $2.34 through 2031. The $1.42 average target implies a -2% move from current prices. That is up +24% on the projected 2030 average. A consolidation phase looks the most probable path here.
The AIMD price prediction for 2032 points to an average of $1.58 (low $1.01, high $2.67) — a potential gain of +9% on today's $1.45. Price action looks broadly range-bound.
In 2033, AIMD is projected to trade between $1.07 and $2.98, averaging $1.72 — a potential gain of +19% from today's $1.45. That is up +9% on the projected 2032 average. A consolidation phase looks the most probable path here.
Ainos, Inc.'s 2034 outlook centres on $1.90, within a $1.15 to $3.36 range. That is up +11% on the projected 2033 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2035, AIMD could reach as high as $3.09, with a base case around $1.71 and support toward $1.01 — roughly +18% from $1.45. A consolidation phase looks the most probable path here.
Expect AIMD to range from $1.35 to $5.05 through 2040. The $2.58 average target implies a +78% move from current prices. That is up +51% on the projected 2035 average. Momentum favours further upside here.
The AIMD price prediction for 2050 points to an average of $3.40 (low $1.53, high $7.47) — a potential gain of +134% on today's $1.45. Buyers look set to stay in control over this stretch.
Investing $1,000 in AIMD today (≈ 689.655172 AIMD) could be worth
$2,344.43
+$1,344.43 (+134%) by 2050 · US Dollar
Based on the average projected AIMD price of $3.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AIMDwould be worth at today's price.
$1,000 invested in AIMD on Jul 31, 2025 (≈ 384.615399 AIMD) would be worth
$557.69
-$442.31 (-44.2%) today · 0.56× · US Dollar
Based on a AIMD entry price of $2.6 vs. today's $1.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.4 | $1,035.71 | +3.6% |
| 1 month ago | $2.04 | $710.78 | -28.9% |
| 3 months ago | $1.72 | $843.02 | -15.7% |
| 6 months ago | $2.28 | $635.96 | -36.4% |
| 1 year ago | $2.6 | $557.69 | -44.2% |
| All time (5.0y) ago | $307.5 | $4.72 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AIMD forecast.
Our base-case forecast reaches $2.90 around 2050.
Implied market cap at $2.90: $21.36M
Looking further out, the multi-year forecast shows a shift from near-term softness to long-term upside. In 2030 the avg price is $1.13 with a -19.5% ROI and BEARISH sentiment, while 2033–2035 move into BULLISH territory with avg prices of $1.77, $1.93 and $1.71 and ROIs of 26.5%, 37.8% and 22.1%, respectively. The forecast strengthens to a 2040 avg of $2.71 and a max of $5.51 (ROI 93.8%), and to 2050 with an avg of $3.51 and a max of $8.04 (ROI 150.5%).
The numbers indicate substantial upside by the end of the forecast horizon, but note the volatility (annualized 90%). These are estimates, not guarantees, and not financial advice.
Tap a question to reveal the answer.
2030 avg $1.13; min $0.7421; max $1.85; ROI -19.5; sentiment BEARISH.
Forecasts show mixed results: near-term 2026 avg $1.40 with ROI 0 and NEUTRAL sentiment; by 2040 the avg is $2.71 with ROI 93.8 and BULLISH sentiment, and by 2050 avg $3.51 with ROI 150.5 and BULLISH sentiment; but volatility is high (annualized 90%).
Yes. The forecast shows a max of $5.51 in 2040 and a max of $8.04 in 2050.
Current price is $1.40 and market cap is $10.31M.
The 30-day range is from $1.04 to $1.88.
Ainos, Inc. Community Discussion
0Share your Ainos, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.